Clinical Trial Update: Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE) [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating the decolonization efficacy of BM111 for carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Colonization
• Vancomycin-resistant Enterococcus Colonization

Drugs mentioned

• BM111

Snippet

Sponsor: BioMe Inc. | Conditions: VRE Colonization, CRE Colonization | NA | Status: ENROLLING_BY_INVITATION